Skip to main content
SpringerLink
Log in

Einsatz von Vitamin-K-Antagonisten und Risiko eines Schlaganfalls oder einer Blutung bei Dialysepatienten mit Vorhofflimmern

Use of vitamin K antagonists and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Zimmermann D, Sood MM, Rigatto C et al (2012) Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 10:3816–3822

    Article  Google Scholar 

  2. Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429

    Article  PubMed  Google Scholar 

  3. Poli D, Antonucci E, Zanazzi M et al (2012) Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb Haemost 107:1100–1106

    Article  CAS  PubMed  Google Scholar 

  4. Olesen JB, Lip GY, Kamper AL et al (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367:625–635

    Article  CAS  PubMed  Google Scholar 

  5. Winkelmayer WC, Liu J, Setoguchi S et al (2011). Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 6:2662–2668

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Herzog CA, Asinger RW, Berger AK et al (2011) Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80:572–586

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

K. Rossen und U. Kunzendorf geben an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Nieren- und Hochdruckkrankheiten, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 12, 24105, Kiel, Deutschland

    K. Rossen & U. Kunzendorf

Authors
  1. K. Rossen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Kunzendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Rossen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossen, K., Kunzendorf, U. Einsatz von Vitamin-K-Antagonisten und Risiko eines Schlaganfalls oder einer Blutung bei Dialysepatienten mit Vorhofflimmern. Nephrologe 9, 469–470 (2014). https://doi.org/10.1007/s11560-014-0898-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-014-0898-5

Search

Navigation